ClinicalTrials.gg
CompletedNCT07038109PRMNURSEUpdated Mar 12, 2026

Progressive Muscle Relaxation in Nursing Students: Effects on Psychological and Biopsychosocial Outcomes

An interventional study of Progressive relaxation exercise in Depression, Anxiety and Stress, Psychological, sponsored by Ondokuz Mayıs University. Completed at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Ondokuz Mayıs University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2025, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Sex
All
01

Study summary

This randomised controlled trial aims to investigate the effects of progressive muscle relaxation exercises (PMRE) on depression, anxiety, stress, future-oriented attitudes, and biopsychosocial responses in nursing students. The study was conducted between June 2024 and June 2025 with students enrolled in the Nursing Department. Data collection took place between January and March 2025. When selecting participants, a list of participants meeting the inclusion criteria was created using snowball sampling. A total of 104 students were randomly divided into experimental and control groups of 52 students each. Data were collected using the DASS-21, Future Orientation Scale, and Biopsychosocial Response Scale for Nursing Students.

Read the detailed description

Nursing students often face academic stress, emotional demands and clinical responsibilities, which can lead to psychological problems such as depression, anxiety, stress and concerns about their future. These issues can affect both their well-being and professional competence. Progressive muscle relaxation exercises (PMRE) are recognised as a useful method for reducing muscle tension, managing stress, and improving emotional regulation.

This randomised controlled trial was conducted between June 2024 and June 2025 with students studying Nursing. The data collection phase was carried out between January and March 2025. Participants meeting the inclusion criteria were identified using snowball sampling, and a list was created. A total of 104 nursing students on this list were randomly assigned to either an experimental group (receiving PMRE) or a control group, with 52 participants in each group. A pre-test-post-test design was used. Measurement tools included the Depression, Anxiety and Stress Scale (DASS-21), the Future Orientation Scale, and the Biopsychosocial Response Scale for Nursing Students.

This study was supported by the Turkish Scientific and Technological Research Council (TÜBİTAK) under the 2209-A University Student Research Projects Support Programme.

02

Conditions studied

  • Depression
  • Anxiety
  • Stress, Psychological
  • Mental Health
  • Students, Nursing
  • Adaptation, Psychological
  • Psychophysiologic Disorders
  • Relaxation Therapy
  • Progressive Relaxation Exercise
  • Progressive Muscle Relaxation Exercise

Keywords

  • Progressive Muscle Relaxation
  • Psychological Intervention
  • Nursing Students
  • Mental Health Promotion
  • Stress Management
  • Depression
  • Anxiety
  • Psychological Stress
  • Biopsychosocial Response
  • Future Orientation
  • University Students
  • Randomized Controlled Trial
  • Relaxation Techniques
  • progressive relaxation exercise
03

In context

Depression

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's enrollment of 104 is above the median of 81 across 7,063 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Ondokuz Mayıs University is the lead sponsor of 277 studies on the registry; 62 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being registered in the Department of Nursing
  • Voluntary consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Having joint or muscle pain, or any condition that may interfere with performing relaxation exercises
  • Having a diagnosis of cancer or any chronic disease
  • Having a psychiatric disorder that may interfere with obtaining valid results from the study (e.g., major depressive disorder, severe anxiety disorders, serious psychiatric conditions)
  • Currently receiving antidepressant, anxiolytic, or similar psychiatric treatment
  • Regular use of non-pharmacological methods such as yoga, psychotherapy, or similar practices
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
104 participants (actual)

Study arms

  • Experimental
    Participants in this group received progressive relaxation exercises (PRE)

    A structured progressive muscle relaxation program based on Jacobson's technique was implemented. The intervention lasted four weeks, with participants practicing three times per week in 45-minute sessions. The exercises were initially demonstrated in person by the researcher to ensure correct technique. Subsequently, participants followed pre-recorded audio instructions during each session to maintain consistency. The intervention aimed to reduce psychological symptoms and support biopsychosocial well-being in nursing students.

    Other: Progressive relaxation exercise

  • No intervention
    Control group

    Participants in this group did not receive any behavioral or psychological intervention during the study period. They continued their normal academic activities without any additional support or guidance. No relaxation techniques or recordings were provided to this group. Data were collected at the same time points as the experimental group to ensure consistency in measurement.

Interventions

  • OtherProgressive relaxation exercise

    The intervention was based on Jacobson's Progressive Muscle Relaxation (PMR) technique. Participants in the experimental group practiced PMR three times per week for four weeks. Each session lasted approximately 45 minutes and was conducted in a quiet environment. In the first session, the researcher provided face-to-face instruction. Subsequent sessions were guided by standardized audio recordings, and the participants were followed through scheduled online video calls. The intervention aimed to reduce depression, anxiety, and stress symptoms and to promote biopsychosocial well-being in nursing students.

    Also known as: progressive muscle relaxation, progressive muscle relaxation exercises, Progressive Relaxation Technique, Jacobson's Progressive Muscle Relaxation, Muscle Relaxation Exercise, Progressive Relaxation Training, Jacobson's progressive relaxation technique

06

What researchers measure

Primary outcomes

  1. Change in depression, anxiety, and stress levels measured by DASS-21

    The Depression Anxiety Stress Scale - 21 (DASS-21) will be used to assess changes in psychological symptoms. It consists of three subscales measuring depression, anxiety, and stress. The scale will be administered at baseline (pre-test) and after the 4-week intervention (post-test).

    Time frame: Baseline and Week 4

Secondary outcomes

  1. Change in future orientation levels measured by the Future Orientation Scale

    The Future Orientation Scale will be used to evaluate students' attitudes toward the future, including goal-setting, planning, and optimism. The scale will be administered before and after the intervention to detect changes.

    Time frame: Baseline and Week 4

  2. Change in biopsychosocial response levels measured by the Biopsychosocial Response Scale for Nursing Students

    This scale measures students' emotional, physical, and social stress-related symptoms. It will be administered at baseline and after the intervention to assess changes in biopsychosocial well-being.

    Time frame: Baseline and Week 4

07

Study locations

1 site
  • Ondokuz Mayıs University
    Samsun, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to ethical restrictions and the scope of the study. The research was conducted as part of a TÜBİTAK 2209-A student project and approved only for academic use. No explicit consent or ethical approval was obtained for external data sharing.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Mar 2025, 2 months.

Of 3,468 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 2 months is below that.

Counting every sponsor, half of 3,566 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2025
First posted
Jun 26, 2025
StartActual
Jan 1, 2025
Primary completionActual
Mar 1, 2025
CompletionActual
Mar 1, 2025
Last update
Mar 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07038109
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Ahsen Taştan Gürkan (Research Assistant, PhD in Nursing, Ondokuz Mayıs University) — Principal investigator
First posted
Jun 26, 2025
Start date
Jan 1, 2025
Primary completion
Mar 1, 2025
Completion
Mar 1, 2025
Last update
Mar 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion